Your Input: | |||||
CHEK2 | Serine/threonine-protein kinase Chk2 isoform B. (433 aa) | ||||
SIRT1 | NAD-dependent protein deacetylase sirtuin-1. (634 aa) | ||||
DDIT4 | DNA damage-inducible transcript 4 protein. (172 aa) | ||||
TMEM109 | Transmembrane protein 109. (182 aa) | ||||
MSH2 | DNA mismatch repair protein; Component of the post-replicative DNA mismatch repair system (MMR). (937 aa) | ||||
BAG6 | Large proline-rich protein BAG6. (945 aa) | ||||
Y1Q_0024039 | KIX domain-containing protein. (131 aa) | ||||
CREBBP | CREB-binding protein isoform C. (2208 aa) | ||||
CDIP1 | Cell death-inducing p53-target protein 1. (259 aa) | ||||
PYCARDL | Apoptosis-associated speck-like protein containing a CARD. (192 aa) | ||||
Y1Q_0017188 | Uncharacterized protein. (164 aa) | ||||
Y1Q_0006003 | Tumor protein p73; Participates in the apoptotic response to DNA damage. Isoforms containing the transactivation domain are pro-apoptotic, isoforms lacking the domain are anti-apoptotic and block the function of p53 and transactivating p73 isoforms. May be a tumor suppressor protein. (688 aa) | ||||
ATAD5 | ATPase family AAA domain-containing protein 5. (1673 aa) | ||||
LITAFL | Lipopolysaccharide-induced tumor necrosis factor-alpha factor. (174 aa) | ||||
TP53 | Cellular tumor antigen p53; Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression; Belongs to the p53 family. (385 aa) | ||||
BRCA2 | Breast cancer type 2 susceptibility protein isoform A. (1174 aa) | ||||
TP63 | Tumor protein 63 (p63); Acts as a sequence specific DNA binding transcriptional activator or repressor. The isoforms contain a varying set of transactivation and auto-regulating transactivation inhibiting domains thus showing an isoform specific activity. May be required in conjunction with TP73/p73 for initiation of p53/TP53 dependent apoptosis in response to genotoxic insults and the presence of activated oncogenes. (730 aa) | ||||
PML | Protein PML isoform B. (586 aa) | ||||
SNW1 | SNW domain-containing protein 1. (536 aa) |